| Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways. | |
| Gao, Yan; Li, Juntong; Chu, Shifeng; Zhang, Zhao; Chen, Naihong; Li, Lin; Zhang, Lan* | |
| 刊名 | European journal of pharmacology
 |
| 2019 | |
| 页码 | 172801 |
| 关键词 | Ginsenoside Rg1 Keap1/Nrf2/HO-1 pathway NLRP3 T1DM |
| DOI | 10.1016/j.ejphar.2019.172801 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5722286 |
| 专题 | 湖南中医药大学 |
| 作者单位 | 1.[Li, Lin 2.Gao, Yan] Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China |
| 推荐引用方式 GB/T 7714 | Gao, Yan,Li, Juntong,Chu, Shifeng,et al. Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.[J]. European journal of pharmacology,2019:172801. |
| APA | Gao, Yan.,Li, Juntong.,Chu, Shifeng.,Zhang, Zhao.,Chen, Naihong.,...&Zhang, Lan*.(2019).Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways..European journal of pharmacology,172801. |
| MLA | Gao, Yan,et al."Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.".European journal of pharmacology (2019):172801. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论